| Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
3,673,602 |
$29,756,176 |
$8.10 |
24 Jan 2024 |
By Medicxi Growth I LP |
| Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
3,641,728 |
$29,497,997 |
$8.10 |
24 Jan 2024 |
By Medicxi IV LP |
| Centessa Pharmaceuticals plc |
10%+ Owner |
Ordinary Shares |
281,162 |
$2,238,050 |
$7.96 |
21 Mar 2022 |
Indirect |
| Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
87,267 |
$706,863 |
$8.10 |
24 Jan 2024 |
By Medicxi Growth Co-Invest I LP |
| Aura Biosciences, Inc. |
10%+ Owner |
Common Stock |
70,540 |
$539,031 |
$7.64 |
02 Nov 2021 |
Indirect |
| Phathom Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
61,975 |
$501,998 |
$8.10 |
24 Jan 2024 |
By Medicxi Co-Invest IV LP |
| RAPT Therapeutics, Inc. |
10%+ Owner |
Common Stock |
21,977,977 |
|
|
27 Dec 2024 |
By Medicxi IV LP |
| RAPT Therapeutics, Inc. |
10%+ Owner |
Common Stock |
374,023 |
|
|
27 Dec 2024 |
By Medicxi Co-Invest IV LP |
| Aura Biosciences, Inc. |
10%+ Owner |
Series D-1 Convertible Preferred Stock |
0 |
|
|
02 Nov 2021 |
Indirect |
| Aura Biosciences, Inc. |
10%+ Owner |
Series D-2 Convertible Preferred Stock |
0 |
|
|
02 Nov 2021 |
Indirect |
| Aura Biosciences, Inc. |
10%+ Owner |
Series E Convertible Preferred Stock |
0 |
|
|
02 Nov 2021 |
Indirect |